Cargando…
Significant association between methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: A meta-analysis update
The methylenetetrahydrofolate reductase (MTHFR) may play a pathological role in polycystic ovary syndrome (PCOS). However, the conclusions of published reports on the relationship between the MTHFR C677T polymorphism and PCOS risk remain controversial. To derive a more precise estimation we performe...
Autores principales: | Li, Yin, Zhu, Hongqiu, Liu, Min, Zeng, Zhulan, Zeng, Yanling, Xu, Xinlei, Ye, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004748/ https://www.ncbi.nlm.nih.gov/pubmed/31977861 http://dx.doi.org/10.1097/MD.0000000000018720 |
Ejemplares similares
-
Methylenetetrahydrofolate reductase C677T polymorphism and the risks of polycystic ovary syndrome: an updated meta-analysis of 14 studies
por: Wang, Lihong, et al.
Publicado: (2017) -
Prevalence of Methylenetetrahydrofolate Reductase
C677T Polymorphism in women with Polycystic
Ovary Syndrome in southeast of Iran
por: Naghavi, A, et al.
Publicado: (2015) -
Identification of the similarly expressed genes in patients with polycystic ovary syndrome and transsexuals
por: Dong, Rong, et al.
Publicado: (2021) -
Lifestyle interventions and quality of life for women with polycystic ovary syndrome: A systematic review and meta-analysis protocol
por: de Lima Nunes, Romilson, et al.
Publicado: (2019) -
The efficacy and safety of metformin combined with simvastatin in the treatment of polycystic ovary syndrome: A meta-analysis and systematic review
por: Liu, Yanbo, et al.
Publicado: (2021)